Trials / Conditions / Ganglioneuroblastoma

Ganglioneuroblastoma

16 registered clinical trials studyying Ganglioneuroblastoma — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma NCT06858501	Children's Oncology Group	Phase 2
Recruiting	Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma NCT07502287	Beijing Biotech	Phase 1 / Phase 2
Recruiting	Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapse NCT07375563	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 3
Recruiting	SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblas NCT05192980	Institut Curie	N/A
Recruiting	Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification NCT06296732	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	—
Recruiting	Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma NCT06071897	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 3
Active Not Recruiting	An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors NCT04040088	Mayo Clinic	EARLY_Phase 1
Active Not Recruiting	Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Ne NCT03786783	National Cancer Institute (NCI)	Phase 2
Recruiting	Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (N NCT03126916	Children's Oncology Group	Phase 3
Active Not Recruiting	Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 NCT02311621	Seattle Children's Hospital	Phase 1
Active Not Recruiting	Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neurobla NCT02176967	Children's Oncology Group	Phase 3
Recruiting	Phase II Study of Proton Radiation Therapy for Neuroblastoma NCT02112617	Massachusetts General Hospital	N/A
Completed	Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed Hig NCT01798004	Children's Oncology Group	Phase 1
Completed	Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With R NCT01767194	National Cancer Institute (NCI)	Phase 2
Completed	Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Ne NCT01175356	Children's Oncology Group	Phase 1
Active Not Recruiting	Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma NCT00904241	Children's Oncology Group	—